GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
- Conditions
- Gastric Content Aspiration
- Registration Number
- NCT05875636
- Lead Sponsor
- Medical University of South Carolina
- Brief Summary
- This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively observing whether the stomach is empty as expected, or contains solid or clinically relevant liquid contents. 
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 260
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
- Name - Time - Method - Retained gastric food - From time of enrollment until the end of surgery, assessed up to 4 weeks - Incidence of clinically significant retained gastric food, defined as visible solid/particulate matter, or liquid volume \> 1.5cc/kg 
- Secondary Outcome Measures
- Name - Time - Method - Incidence of pulmonary aspiration event - From the time surgery begins until the end of scheduled surgery, assessed up to 24 hours 
Trial Locations
- Locations (1)
- Medical University of South Carolina πΊπΈ- Charleston, South Carolina, United States Medical University of South CarolinaπΊπΈCharleston, South Carolina, United States
